Geoffrey Grandjean

Publications

436

Citations

H-Index

2009

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Discovery Institute

Hôpital Saint-Jacques

Centre Hospitalier Universitaire de Nantes

Geoffrey Grandjean is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, infection control, and clinical microbiology.

Top concepts

MedicineCell BiologyEpidemiologyMicrobiologyTumor BiologyCancer BiologyInfection ControlRadiation OncologyClinical MicrobiologyAntimicrobial Resistance

Publications per year

2009–2019

Publications

SIK2 Is a Centrosome Kinase Required for Bipolar Mitotic Spindle Formation that Provides a Potential Target for Therapy in Ovarian Cancer

Ahmed A. Ahmed, Zhen Lü, Nicholas B. Jennings et al. · Cancer Cell · 2010 · 142 citations · Full text

Signaling Pathway, Cell Division, Medicine +10

Definition of a Novel Feed-Forward Mechanism for Glycolysis-HIF1α Signaling in Hypoxic Tumors Highlights Aldolase A as a Therapeutic Target

Geoffrey Grandjean, Petrus R. de Jong, Brian P. James et al. · Cancer Research · 2016 · 78 citations

Prevalence of extended-spectrum beta-lactamase producing Escherichia coli in community-onset urinary tract infections in France in 2013

David Viana Martín, Sébastien Fougnot, F. Grobost et al. · Journal of Infection · 2015 · 58 citations · Full text

Antimicrobial Susceptibility, Extended-spectrum Beta-lactamase, Health Sciences +9

Modulating Microtubule Stability Enhances the Cytotoxic Response of Cancer Cells to Paclitaxel

Ahmed A. Ahmed, Xiaoyan Wang, Zhen Lü et al. · Cancer Research · 2011 · 54 citations · Full text

Cell Death, Cytotoxic Response, Sirna Screen +17

A new HIF‐1α/RANTES‐driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF in mice

Mei Yee Koh, Mihai Gagea, Timothy Sargis et al. · Hepatology · 2016 · 44 citations · Full text

Rows per page

1–5 of 7